- Home
- CVAC vs FDUS Comparison
CVAC vs FDUS Comparison
Compare CVAC & FDUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- FDUS
- Stock Information
- Founded
- CVAC 2000
- FDUS 2011
- Country
- CVAC Germany
- FDUS United States
- Employees
- CVAC N/A
- FDUS N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- FDUS Finance/Investors Services
- Sector
- CVAC Health Care
- FDUS Finance
- Exchange
- CVAC Nasdaq
- FDUS Nasdaq
- Market Cap
- CVAC 764.4M
- FDUS 654.0M
- IPO Year
- CVAC 2020
- FDUS 2011
- Fundamental
- Price
- CVAC $4.47
- FDUS $20.49
- Analyst Decision
- CVAC Strong Buy
- FDUS Hold
- Analyst Count
- CVAC 2
- FDUS 1
- Target Price
- CVAC $14.00
- FDUS $20.00
- AVG Volume (30 Days)
- CVAC 779.9K
- FDUS 167.1K
- Earning Date
- CVAC 05-20-2025
- FDUS 05-08-2025
- Dividend Yield
- CVAC N/A
- FDUS 11.06%
- EPS Growth
- CVAC N/A
- FDUS N/A
- EPS
- CVAC 0.87
- FDUS 2.33
- Revenue
- CVAC $566,039,775.00
- FDUS $147,999,000.00
- Revenue This Year
- CVAC N/A
- FDUS $2.50
- Revenue Next Year
- CVAC $37.79
- FDUS $8.20
- P/E Ratio
- CVAC $5.16
- FDUS $8.80
- Revenue Growth
- CVAC 787.60
- FDUS 9.06
- 52 Week Low
- CVAC $2.37
- FDUS $16.70
- 52 Week High
- CVAC $5.28
- FDUS $23.55
- Technical
- Relative Strength Index (RSI)
- CVAC 65.61
- FDUS 61.49
- Support Level
- CVAC $3.35
- FDUS $19.75
- Resistance Level
- CVAC $4.80
- FDUS $20.77
- Average True Range (ATR)
- CVAC 0.30
- FDUS 0.35
- MACD
- CVAC 0.07
- FDUS 0.07
- Stochastic Oscillator
- CVAC 77.51
- FDUS 75.22
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About FDUS Fidus Investment Corporation
Fidus Investment Corp is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company. The company provides customized debt and equity financing solutions to lower middle-market companies. Its investment objective is to provide attractive risk-adjusted returns by generating both current income from debt investments and capital appreciation from equity related investments. The company's portfolio of investments is comprised of securities of companies from different industries such as, Information Technology Services, Business Services, Healthcare Products among others.